Caroline Young - 14 Apr 2022 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Caroline Young by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
14 Apr 2022
Net transactions value
+$559
Form type
4
Filing time
06 May 2022, 17:09:58 UTC
Previous filing
29 Apr 2022
Next filing
10 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Purchase $51.49 +19 +0.12% $2.71 15,796 14 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $49.97 +19 +0.12% $2.63 15,815 18 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $51.11 +19 +0.12% $2.69 15,834 19 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $52.06 +19 +0.12% $2.74 15,853 20 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $52.25 +19 +0.12% $2.75 15,872 21 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $51.87 +19 +0.12% $2.73 15,891 22 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $52.4 +20 +0.13% $2.62 15,911 25 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $50.6 +20 +0.13% $2.53 15,931 26 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $48.2 +20 +0.13% $2.41 15,951 27 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $50.2 +20 +0.13% $2.51 15,971 28 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $48.8 +20 +0.13% $2.44 15,991 29 Apr 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.